Semper Paratus Acquisition Corp
Status: Deal Closed
U=S+W/2
W=S@11.50
IPO Proceeds, $M | $345.00M |
---|---|
IPO Date | Nov 4, 2021 |
CEO | Surendra Ajjarapu |
Left Lead | Cantor Fitzgerald |
IPO Cash in Trust | 102.0% |
SPAC Tenor | 15 + 10 + 9 |
IPO Sector |
Industrial
Transportation, supply chain and logistics |
IPO Geography | Global |
Target Company | Tevogen Bio |
Deal Announced | Jun 29, 2023 |
Deal Size, $M | $1,200.00M |
Deal Sector | Healthcare |
Deal Geography | US/Canada |
SEC Filings | www.sec.gov |
Approval Vote | Jan 29, 2024 |
Amendment Vote | Dec 14, 2023 |
Closing Date | Feb 14, 2024 |
Formerly LGST
TVGN
TVGNW
Price | $1.44 |
---|---|
Last closing price | $1.36 |
H/L, today | $1.40 / $1.76 |
Volume, today | 20,773,988 |
Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on Semper Paratus Acquisition Corp:
- Structure and cap table
- 6 directors & officers
- 29 filings and events
- 1 underwriters
- 3 deal advisors
- 2 legal advisors
Structure
Sign in to view structure, cap table, and calendar of events.
Team
Name | Age | Title |
---|---|---|
Surendra Ajjarapu | CEO & Chairman | |
Francis Knuettel II | CFO | |
Michael Peterson | Director | |
Donald Fell | Director | |
Avinash Wadhwani | Director | |
Scott Sussman | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
Cantor Fitzgerald | BR | 30,000,000 | units |
30,000,000 | units | ||
Up-Front UW fee | 2.00 | % | |
Deferred UW fee |
4.26 | % |
Sign in to view more advisor data.
Deal
Sign in to view merger details and deal financials.